Edesa Biotech, Inc. financial data

Symbol
EDSA on Nasdaq
Location
100 Spy Court, Markham, Ontario, Canada
Fiscal year end
September 30
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 581 % +152%
Debt-to-equity 55.5 % +192%
Return On Equity -69.8 % +49.4%
Return On Assets -60.3 % +38.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.04M shares +117%
Common Stock, Shares, Outstanding 7.02M shares +116%
Entity Public Float 11.1M USD
Common Stock, Value, Issued 54.3M USD +14.9%
Weighted Average Number of Shares Outstanding, Basic 7.02M shares +118%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.55M USD -31.7%
General and Administrative Expense 3.9M USD -16.1%
Operating Income (Loss) -6.45M USD +23.1%
Nonoperating Income (Expense) 527K USD -63.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.75M USD -4.87%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -5.92M USD +14.6%
Earnings Per Share, Basic -1 USD/shares +51.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.4M USD
Assets, Current 12.8M USD +319%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 2.21M USD
Assets 14.8M USD +183%
Liabilities, Current 673K USD -71.5%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 1.83M USD -0.48%
Accumulated Other Comprehensive Income (Loss), Net of Tax -123K USD +45.2%
Retained Earnings (Accumulated Deficit) -63.6M USD -10.4%
Stockholders' Equity Attributable to Parent 14.1M USD +393%
Liabilities and Equity 14.8M USD +183%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.52M USD -7.87%
Net Cash Provided by (Used in) Financing Activities 2.07M USD +578%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares, Issued 7.02M shares +116%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 526K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.4M USD +506%
Deferred Tax Assets, Valuation Allowance 18.1M USD +9.77%
Deferred Tax Assets, Gross 18.2M USD +8.99%
Operating Lease, Liability 19.9K USD -79%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.82M USD +16.5%
Lessee, Operating Lease, Liability, to be Paid 20K USD -79.9%
Property, Plant and Equipment, Gross 52.5K USD 0%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20K USD -0.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 20K USD -74.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 152 USD
Preferred Stock, Shares Issued 150 shares
Operating Lease, Payments 17.9K USD -11.1%
Additional Paid in Capital 14.4M USD +6.85%
Amortization of Intangible Assets 30K USD 0%
Depreciation, Depletion and Amortization 43.1K USD -4.27%
Deferred Tax Assets, Net of Valuation Allowance 126K USD -45.9%
Share-based Payment Arrangement, Expense 200K USD +100%